Cargando…
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated with Interferon Beta or Glatiramer Acetate
The participation of proinflammatory cytokines in the progression of Multiple Sclerosis (MS) has been well documented. Cytokines activate the JAK-STAT pathway, in which the suppressors of cytokine signaling (SOCS) exert a negative feedback. This paper analyzes the levels of SOCS5 and SOCS7 transcrip...
Autores principales: | Rojas-Morales, Emmanuel, Santos-López, Gerardo, Hernández-Cabañas, Samuel, Arcega-Revilla, Raúl, Rosas-Murrieta, Nora, Jasso-Miranda, Carolina, El-Kassis, Elie Girgis, Reyes-Leyva, Julio, Sedeño-Monge, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982240/ https://www.ncbi.nlm.nih.gov/pubmed/31905601 http://dx.doi.org/10.3390/ijms21010218 |
Ejemplares similares
-
IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever
por: Flores-Mendoza, Lilian Karem, et al.
Publicado: (2017) -
Effects of valproic acid on SOCS-1, SOCS-2, SOCS-3, SOCS-5, SOCS6, and SOCS-7 gene expression and cell growth inhibition in colon carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2022) -
Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018) -
Glatiramer acetate treatment negatively regulates type I interferon signaling
Publicado: (2015) -
Glatiramer acetate treatment negatively regulates type I interferon signaling
por: Molnarfi, Nicolas, et al.
Publicado: (2015)